Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 06 Sep 2021 |
2 | Reply to Exam Report (MIS-R) | 24 Sep 2021 |
3 | Journal Copy | 16 Nov 2023 |
4 | Certificate | 03 Feb 2024 |
1 | EXAMINATION REPORT | 12194978 | 22 Sep 2021 | |
2 | Hearing Notice (Show Cause) | 13259865 | 29 Mar 2022 | |
3 | Hearing Notice (Show Cause) | 13702905 | 27 Jun 2022 | |
4 | Hearing Notice (Show Cause) | 14528101 | 22 Dec 2022 | |
5 | Hearing Notice (Show Cause) | 15145951 | 25 Apr 2023 | |
6 | Hearing Notice (Show Cause) | 15532380 | 03 Jul 2023 | |
7 | Tribunal Accepted Notice for : 5119325 | 15763352 | 6096300 | 04 Aug 2023 |
Trademark was applied on 06 September 2021 with IP India.
Proprietor of Ursodiliv is RELIABO PHARMA INDIA.
Class(es) in which the trademark was applied to is 5.
Status of Ursodiliv is Registered.
Application number alloted to the trademark is 5119325.
D. Sen & Co is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD